Your browser doesn't support javascript.
loading
Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
Wu, Min; Wu, Lingxiang; Wu, Wei; Zhu, Mengyan; Li, Jianyu; Wang, Ziyu; Li, Jie; Ding, Rong; Liang, Yuan; Li, Liangyu; Zhang, Tingting; Huang, Bin; Cai, Yun; Li, Kening; Li, Lu; Zhang, Rui; Hu, Baoli; Lin, Fan; Wang, Xiuxing; Zheng, Siyuan; Chen, Jian; You, Yongping; Jiang, Tao; Zhang, Junxia; Chen, Hongshan; Wang, Qianghu.
Affiliation
  • Wu M; The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
  • Wu L; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Wu W; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Zhu M; The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
  • Li J; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Wang Z; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Li J; The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
  • Ding R; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Liang Y; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Li L; The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing, China.
  • Zhang T; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Huang B; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Cai Y; Chinese Institute for Brain Research Beijing (CIBR), Beijing, China.
  • Li K; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Li L; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Zhang R; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Hu B; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Lin F; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Wang X; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Zheng S; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Chen J; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • You Y; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Jiang T; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Zhang J; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
  • Chen H; Institute for Brain Tumors, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
  • Wang Q; Department of Bioinformatics, Nanjing Medical University, Nanjing, China.
Cancer Res ; 83(5): 771-785, 2023 03 02.
Article in En | MEDLINE | ID: mdl-36622331
ABSTRACT
Tumor-associated macrophages (TAM) play a crucial role in immunosuppression. However, how TAMs are transformed into immunosuppressive phenotypes and influence the tumor microenvironment (TME) is not fully understood. Here, we utilized single-cell RNA sequencing and whole-exome sequencing data of glioblastoma (GBM) tissues and identified a subset of TAMs dually expressing macrophage and tumor signatures, which were termed double-positive TAMs. Double-positive TAMs tended to be bone marrow-derived macrophages (BMDM) and were characterized by immunosuppressive phenotypes. Phagocytosis of glioma cells by BMDMs in vitro generated double-positive TAMs with similar immunosuppressive phenotypes to double-positive TAMs in the GBM TME of patients. The double-positive TAMs were transformed into M2-like macrophages and drove immunosuppression by expressing immune-checkpoint proteins CD276, PD-L1, and PD-L2 and suppressing the proliferation of activated T cells. Together, glioma cell phagocytosis by BMDMs in the TME leads to the formation of double-positive TAMs with enhanced immunosuppressive phenotypes, shedding light on the processes driving TAM-mediated immunosuppression in GBM.

SIGNIFICANCE:

Bone marrow-derived macrophages phagocytose glioblastoma cells to form double-positive cells, dually expressing macrophage and tumor signatures that are transformed into M2-like macrophages and drive immunosuppression.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phagocytosis / Glioblastoma / Glioma / Macrophages Limits: Humans Language: En Journal: Cancer Res Year: 2023 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phagocytosis / Glioblastoma / Glioma / Macrophages Limits: Humans Language: En Journal: Cancer Res Year: 2023 Type: Article Affiliation country: China